OB/GYN: A Comprehensive Review

Publisher: CMEInfo
Credits: 31.5
Credit Type: AMA PRA Category 1
Price: $995 - $1,395
Format: Online Video, CD, MP3 DVD MP4
Release Date: 6/15/2014
Expiration Date: 6/15/2017
Tags: cme , cmeinfo

The OB/GYN: A Comprehensive Review course is designed to focus on common yet intricate obstetric and gynecologic medical problems and targets ideas where the quality of care can be advanced. Specific medical subject that will be presented in individual lectures and interactive case based learning include: termination of pregnancy, abnormal uterine bleeding, endometriosis, sexually transmitted diseases, pelvic pain, uterine fibroids/myomas, contraception for women with medical problems, vaginitis, pelvic organ prolapse, polycystic ovary syndrome, infertility, vulvar disorders, sexual dysfunction, menopausal symptoms, cervical dysplasia, cancer of the genital tract, preconception counseling, drugs and medication use during pregnancy, chronic and complex medical problems in pregnancy, thrombophilias and venous thrombosis in women, diabetes in pregnancy, preterm labor, twin and triplet pregnancy, preeclampsia, obstetrical hemorrhage, and management of labor and delivery. For all topics listed above, nationally recognized and clinically active experts dicuss the gaps in their area of expertise. Gaps are identified by the experts based on the observed pattern of practice in their community and the gaps in care received by patients referred to them for consultation. Gaps are identified also by understanding what the scientific evidence suggests should be done in practice and what is actually done in community practice. An example of a gap observed between current and recommended practice is in cervical cancer screening as outlined above. Guidelines published since 2009 by ASCCP recommend that cervical cancer screening with a PAP smear be initiated at age 21 years, but based upon retrospective review of claims data across the United States in 2010, greater than 55% of women younger than 21 years underwent cervical cancer screening. IN addition, while national guidelines recommend cervical cancer screening every 3 years for women ages 21-29 years, a January 2013 publication by MMWR reports a 36% increase in women who have never been screened in this age group. Our faculty will address the most updated cervical cancer screening guidelines as well as characterize appropriate treatment and follow-up for cervical dysplasia.
Rating Summary:
0 based on 0 votes

Sign Up For Our Newsletter!

Find us on Facebook!
Find us on Twitter!
Find us on Pinterest!